Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AB Interferons
L03AB08 Interferon beta-1b
D00746 Interferon beta-1b (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Multiple Sclerosis Agents
Interferon Beta-1b
D00746 Interferon beta-1b (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
639 Miscellaneous
6399 Others
D00746 Interferon beta-1b (USAN/INN); Interferon beta-1b (genetical recombination) (JAN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01751 Interferon beta
D00746 Interferon beta-1b
Drug classes [BR:br08332]
Immunological agent
DG01752 Interferone
D00746 Interferon beta-1b
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interferon receptors
IFNAR1
D00746 Interferon beta-1b (USAN/INN) <JP/US>
IFNAR2
D00746 Interferon beta-1b (USAN/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00746
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00746
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01751 Interferon beta